HOME >> BIOLOGY >> NEWS
JCI Table of Contents, April 1, 2003

The Latest RAGE in Restinosis
Expansion of the neointima is a problem in chronic atherosclerosis as well as in response to acute arterial injury. Smooth muscle cells (SMCs) play a key role in the pathologic extension of the neointima that ultimately impinges on the vascular lumen. RAGE, the receptor for advanced glycation end products, is upregulated at sites of vascular pathology, and its blockage is beneficial in mouse atherosclerosis models. Yoshifumi Naka and colleagues have examined RAGE's role in acute arterial injury. As they report (pages 959972), inhibition of RAGE suppressed neointimal formation in mice upon arterial injury and decreased SMC proliferation, migration, and expression of ECM proteins. Inhibition of RAGE specifically in SMCs yielded similar results. The data point to a key role for RAGE in regulating SMCs after arterial injury and suggest the receptor as a target for therapeutic intervention in heart disease.

CONTACT:
Taichi Sakaguchi
Columbia University
New York, NY 10032
USA
Phone: 1-212-305-0211
Fax: 1-212-305-5337
E-mail: ts472@columbia.edu

View the PDF of this article at:
https://www.the-jci.org/press/17115.pdf

Spreading Mucosal Immunity
Local mucosal immunization leads to antigen-specific IgA production at distant mucosal sites, presumably through the migration of activated B cells. Because of the important implications for vaccine development, Eric Kunkel and colleagues are working to understand the mechanisms of IgA-secreting B cell trafficking between distant mucosal sites. Having previously identified a chemokine called MEC, which is expressed by epithelial cells in a variety of mucosal tissues, they report now (pages 10011010) that the MEC-binding chemokine receptor CCR10 is expressed on IgA-secr
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
1-Apr-2003


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. JCI Table of Contents, 15 July 2004
2. JCI Table of Contents, January 15 2004
3. JCI Table of Contents, November 3, 2003
4. JCI Table of Contents, 1 October, 2003
5. JCI Table of Contents, September 15, 2003
6. JCI Table of Contents
7. JCI Table of Contents, 15 August 2003
8. JCI Table of Contents, May 1, 2003
9. JCI Table of Contents, March 14, 2003
10. JCI Table of Contents, January 2, 2003
11. JCI Table of Contents, December 2, 2002

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2019)... ... 2019 , ... Molecular diagnostics segment is the fastest-growing segment within the global ... Major segments that are expected to drive the growth are infectious diseases, cancer, and ... in Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The discovery ...
(Date:6/11/2019)... , ... June 12, 2019 , ... ... antibody discovery services, Abveris plans to leverage the Geneious Biologics platform as a ... Souders, Chief Technology Officer at Abveris, says: “The Geneious team has done an ...
(Date:6/6/2019)... ... June 05, 2019 , ... Pelican BioThermal , ... station and service center in Mexico City, Mexico. Mexico is the second largest ... more than $1.75 billion in pharmaceutical exports since 2015. The Mexico City network ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... April 16, 2019 , ... On ... project partner, the U.S. Army Center for Environmental Health Research (USACEHR), with an ... In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the Frederick Innovative Technology ...
(Date:4/15/2019)... ... 15, 2019 , ... Sirrus, Inc., a developer of novel ... expansion to increase production of methylene malonate monomers and oligomers. , The expanded ... full-scale production facility, which is scheduled to break ground in 2019. “The expanded ...
(Date:4/10/2019)... (PRWEB) , ... April 10, ... ... both regenerative medicine manufacturing technology leaders, have locked into multiple agreements to ... before. Companies across the regenerative medicine industry, ranging from synthetic biology companies ...
(Date:4/9/2019)... ... 09, 2019 , ... USDM Life Sciences , the ... organizations to accelerate innovation and maximize productivity, announces that nearly 100 companies have ... , USDM’s Cloud Assurance is a managed subscription service delivering end-to-end ...
Breaking Biology Technology:
Cached News: